BioCheck acquires DRG

LabPulse.com staff writers
Aug 17, 2021
2020 03 25 23 27 0591 Hands Shaking Deal 400

BioCheck has acquired clinical diagnostic and research manufacturer DRG International, which manufactures clinical diagnostic and research enzyme-linked immunosorbent (ELISA) assays and has distributors in over 110 countries.

BioCheck plans to integrate its assay development capabilities with DRG's development center, IVD development, manufacturing, and sales channels. The company believes the combination will improve distribution of existing assays and speed up development of novel ELISAs and chemiluminescent immunoassay platforms.

The terms of the deal were not disclosed.

Latest in Collaboration
Blood Test Samples Lab Social
Scipher Medicine, Quest Diagnostics collaborate on RA diagnostics
November 28, 2023
Hands Shaking Deal Social
AnchorDx, DiaCarta to collaborate on cancer diagnostics
November 14, 2023
Dna Genome Gene Targeted Social
US ambassador visits NGS laboratory in India
October 30, 2023
Global Collaboration Business Social
Qiagen, Myriad Genetics to collaborate on cancer companion diagnostics
October 27, 2023
Related Stories
2021 06 30 22 19 4138 Digital Science Lab 400
Collaboration
Lucid launches EsoGuard pilot test at centers in Ariz.
2019 04 26 21 48 5250 Money Hundred Bills 400
Collaboration
CAP to raise $2M to support cancer screening
2021 08 06 16 17 5155 Cancer Cell Microenvironment 400
Collaboration
Research finds tissue changes that may lead to cancer cells
2021 07 20 21 45 9618 Businessman Shake Hand Collegue 400
Collaboration
Lyniate wins contract from Diagnostic Support Services
More in Collaboration
Scipher Medicine, Quest Diagnostics collaborate on RA diagnostics
Scipher Medicine and Quest Diagnostics have announced a multiyear collaboration to expand access to diagnostic services for patients with rheumatoid arthritis (RA).
November 28, 2023
Blood Test Samples Lab Social
AnchorDx, DiaCarta to collaborate on cancer diagnostics
Biotech company AnchorDx has entered into a long-term partnership with molecular diagnostics firm DiaCarta to develop and commercialize cancer diagnostic products for the global market.
November 14, 2023
Hands Shaking Deal Social
US ambassador visits NGS laboratory in India
There is growing bilateral cooperation in cancer research, prevention, control, and management, where leaders said they looked forward to the launch of the India-U.S. Cancer Dialogue.
October 30, 2023
Dna Genome Gene Targeted Social
Qiagen, Myriad Genetics to collaborate on cancer companion diagnostics
Qiagen and Myriad Genetics have formed a new master collaboration agreement on the development of companion diagnostic tests for cancer.
October 27, 2023
Global Collaboration Business Social
Versant Diagnostics to collaborate with Dahl-Chase Pathology and Diagnostics
Independent physicians services group Versant Diagnostics is collaborating with Bangor, ME-based Dahl-Chase Pathology Associates and Diagnostic Services.
October 25, 2023
Business Men Handshake Social
Sophia Genetics, AstraZeneca, Memorial Sloan Kettering to collaborate on cancer test access
Sophia Genetics is collaborating with Memorial Sloan Kettering (MSK) Cancer Center and AstraZeneca to expand MSK's genomic sequencing tests to a global scale, with the aim of by providing more inclusive access to cancer testing worldwide.
October 20, 2023
Cancer Cell Target2 Social
Boehringer Ingelheim, Thermo Fisher to collaborate on CDx development for NSCLC
Boehringer Ingelheim and Thermo Fisher have formed a partnership to develop companion diagnostic (CDx) tests for identifying patients with non-small cell lung cancer (NSCLC) with specific genomic mutations who may benefit from targeted therapies.
October 19, 2023
Lung 3 D Social
ARUP launches new collaborative research institute
ARUP Industries is hoping to “push the boundaries of diagnostic medicine” via the launch of a new research institute that aims to forge collaborations with industry and community partners.
October 18, 2023
Lab Scientist Computer Ai Social
Twist Bioscience, Bayer enter agreement on antibody discovery and licensing
Twist Bioscience and Bayer have signed an antibody discovery, option, and licensing agreement.
October 9, 2023
Business Men Handshake Social
Oxford Nanopore collaboration makes classroom DNA sequencing accessible
An ambition to make in-classroom DNA sequencing routinely available, more user-friendly, and more egalitarian in U.S. universities and schools has been set out by a leading genetics educator.
October 9, 2023
Dna Sequencing Data Analysis Social
Ginkgo Bioworks, Pfizer collaborate on RNA-based therapeutics
Cell engineering company Ginkgo Bioworks has entered into an agreement with Pfizer to discover and develop RNA-based drug candidates.
September 28, 2023
Rna Strand Social
Exact Sciences, Watchmaker Genomics partner to improve DNA methylation technology
Exact Sciences has partnered with Watchmaker Genomics to develop and commercialize technology for analyzing DNA methylation.
September 6, 2023
Dna Genome Gene Targeted Social
Page 1 of 38
Next Page